Produkty 113891-94-4

CAS 113891-94-4 występuje w naszej ofercie pod nazwami: 6Alpha-Hydroxy-17Alpha-acetoxyprogesterone, 6a-Hydroxy-17a-acetoxyprogesterone. Oferty producentów: TRC. Dostępne opakowania: 10mg, 25mg, 50mg.

6Alpha-Hydroxy-17Alpha-acetoxyprogesterone
TRC
  • opakowanie: 10mg, 25mg
  • Warianty: 2
Zobacz produkt
6a-Hydroxy-17a-acetoxyprogesterone
TRC
  • opakowanie: 50mg
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate (CAS 113891-94-4) to związek chemiczny o wzorze sumarycznym C23H32O5 i masie molowej 388.5 g/mol. Nazwa systematyczna IUPAC: [(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate. InChIKey: OGLKITGHAYOASS-WXLIAARGSA-N.

Dane identyfikacyjne
Wzór sumarycznyC23H32O5
Masa molowa388.5 g/mol
Nazwa IUPAC[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
InChIKeyOGLKITGHAYOASS-WXLIAARGSA-N
SMILESCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@@H](C4=CC(=O)CC[C@]34C)O)C)OC(=O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 6a-Hydroxy-17a-acetoxyprogesterone, 6Alpha-Hydroxy-17Alpha-acetoxyprogesterone
Powiązane formy tego związku
[(6R,8R,9S,10R,13S,14S,17R)-17-acetyl-6-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C23H32O5
Izomery (ten sam wzór sumaryczny)
[(1S,3S,7S,8S,8aR)-3-hydroxy-7-methyl-8-[2-[(2R)-6-oxo-2,3-dihydropyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate C23H32O5
(E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoic acid C23H32O5
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxo-5-phenylpentyl)cyclopentyl]hept-5-enoic acid C23H32O5
(Z)-3,3,4,4-tetradeuterio-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoic acid C23H32O5
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoic acid C23H32O5
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoic acid C23H32O5
[2-[(8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H32O5
[(6S,9R,13R)-6-hydroxy-13-methyl-16-oxo-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icos-17-en-6-yl]methyl acetate C23H32O5
[(2R,8R,9S,10R,13S,14S,17S)-2-acetyloxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate C23H32O5
[(2R,8R,9S,10R,13S,14S,17R)-2-acetyloxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate C23H32O5
3-[(5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-10,13-dimethyl-3-oxo-2,4,5,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one C23H32O5